Status:
WITHDRAWN
Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Unspecified Adult Solid Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may b...
Detailed Description
PRIMARY OBJECTIVES: I. To obtain patient images in a clinical setting and assess their quality. SECONDARY OBJECTIVES: I. To assess the registration agreement through a voxel-voxel distance-to-agree...
Eligibility Criteria
Inclusion
- Patients who are scheduled to receive either an optical or CBCT imaging scan as part of their treatment management.
- The study will be open to English and Spanish speaking participants.
Exclusion
- Patients that are not scheduled for fluoroscopic or optical imaging as part of the normal course of radiotherapy.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03789773
Start Date
December 1 2022
End Date
December 1 2024
Last Update
February 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033